[Partial elective nephrectomy]
- PMID: 21955560
- DOI: 10.1016/j.acuro.2011.06.016
[Partial elective nephrectomy]
Abstract
Introduction: Partial nephrectomy is widely accepted as a therapeutic modality in renal cell carcinoma (RCC) in patients with single kidney, bilateral tumor or deteriorated renal function. Currently, long-term survival studies have consolidated partial nephrectomy as the treatment of choice for RCC in selected patients with normal contralateral kidney.
Material and methods: Between July 1990 and January 2008, a total of 102 partial nephrectomy were performed on 100 patients with pre-operative ultrasonography diagnosis of renal carcinoma in 94 cases and complex renal cysts in 6 cases. The pre-operative ultrasonography size varied from 1.5 to 10 cm with an average of 4.85 cm.
Results: Tumor size was correlated with the pathological stage, finding tumors in stage pT1 with sizes less than and greater than 4 cm in 74% and 64%, respectively, and in stage pT2 of 3.7% and 5.4%. Tumor size measured by pre-operative CT scan was compared with the definitive size of the pathology specimen in 93 cases (56<4 cm and 37>4 cm, according to the CT scan). We found high concordance, however in the larger tumors, there was a tendency of the CT scan to overestimate the size. A post-operative gamma scintigraphy with DMSA was performed in 40 patients. The values in the tumors <4 cm (21 patients) were 12-77% (average 43.3%). In tumors between 4 and 7 cm (17 patients), the values were 13.8-53.3% (average 37.6%) and in 2 cases of tumors >7 cm the post-operative DMSA showed 47.5 and 51%.
Conclusions: Partial nephrectomy is currently accepted as elective treatment in incidental kidney tumors less than 4 cm and it is indicated increasingly more frequently in larger tumors and of central localization. The finding of benign pathology in the anatomic-pathology specimen in up to 20% of the incidental renal tumors and low potential of malignancy of the possible satellite lesions in the remnant kidney also support nephron-sparing surgery in these tumors.
Copyright © 2011 AEU. Published by Elsevier Espana. All rights reserved.
Similar articles
-
Elective nephron sparing surgery for renal cell carcinoma larger than 4 cm.J Urol. 2008 Jan;179(1):71-4; discussion 74. doi: 10.1016/j.juro.2007.08.165. Epub 2007 Nov 12. J Urol. 2008. PMID: 17997423
-
Renal cell carcinoma: evaluation of the 1997 TNM system and recommendations for follow-up after surgery.Eur Urol. 2001 Jun;39(6):669-74; discussion 675. doi: 10.1159/000052525. Eur Urol. 2001. PMID: 11464056
-
Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.BJU Int. 2012 Oct;110(7):956-60. doi: 10.1111/j.1464-410X.2012.10937.x. Epub 2012 Feb 2. BJU Int. 2012. PMID: 22300498
-
Expanding indication for elective nephron-sparing surgery in renal cell carcinoma.Arch Ital Urol Androl. 2009 Jun;81(2):86-90. Arch Ital Urol Androl. 2009. PMID: 19760862 Review.
-
Renal cell carcinoma: presentation, staging, and surgical treatment.Semin Oncol. 2000 Apr;27(2):160-76. Semin Oncol. 2000. PMID: 10768595 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical